about
Protein kinase C switches the Raf kinase inhibitor from Raf-1 to GRK-2RKIP: a governor of intracellular signalingCrosstalk between sentinel and helper macrophages permits neutrophil migration into infected uroepithelium.Cardiac amyloidosis mimicking severe aortic valve stenosis - a case report demonstrating diagnostic pitfalls and role of dobutamine stress echocardiography.Phosphorylation or Mutation of the ERK2 Activation Loop Alters Oligonucleotide Binding.Cardiac hypertrophy: targeting Raf/MEK/ERK1/2-signaling.Eukaryotic elongation factor 2 is a prognostic marker and its kinase a potential therapeutic target in HCC.Heart failure-specific changes in protein kinase signalling.Analyzing ERK 1/2 signalling and targets.β-Arrestin biosensors reveal a rapid, receptor-dependent activation/deactivation cyclePKA catalytic subunit mutations in adrenocortical Cushing's adenoma impair association with the regulatory subunit.Multi-OMICS: a critical technical perspective on integrative lipidomics approaches.Raf kinase inhibitor protein: lessons of a better way for β-adrenergic receptor activation in the heart.beta-Arrestin-2 interaction and internalization of the human P2Y1 receptor are dependent on C-terminal phosphorylation sites.Conformational cross-talk between alpha2A-adrenergic and mu-opioid receptors controls cell signaling.Beta-arrestin binding to the beta2-adrenergic receptor requires both receptor phosphorylation and receptor activation.Loss of Survivin influences liver regeneration and is associated with impaired Aurora B function.The amino-terminal domain of G-protein-coupled receptor kinase 2 is a regulatory Gbeta gamma binding site.Differences in natural history of low- and high-gradient aortic stenosis from nonsevere to severe stage of the disease.CD28 superagonist-mediated boost of regulatory T cells increases thrombo-inflammation and ischemic neurodegeneration during the acute phase of experimental stroke.β 1 Adrenoceptor antagonistic effects of the supposedly selective β 2 adrenoceptor antagonist ICI 118,551 on the positive inotropic effect of adrenaline in murine hearts.Inhibition of cardiac CaMKII to cure heart failure: step by step towards translation?Partial agonist activity of bucindolol is dependent on the activation state of the human beta1-adrenergic receptor.A new type of ERK1/2 autophosphorylation causes cardiac hypertrophy.The β2 agonist terbutaline specifically decreases pulmonary arterial pressure under normoxia and hypoxia via α adrenoceptor antagonism.Conserved salt-bridge competition triggered by phosphorylation regulates the protein interactome.Sex-difference in expression and function of beta-adrenoceptors in macrovessels: role of the endothelium.Cardiac RKIP induces a beneficial β-adrenoceptor-dependent positive inotropy.Phosphodiesterase 2 Protects Against Catecholamine-Induced Arrhythmia and Preserves Contractile Function After Myocardial Infarction.FTY720 ameliorates acute ischemic stroke in mice by reducing thrombo-inflammation but not by direct neuroprotection.Ectopic expression of S28A-mutated Histone H3 modulates longevity, stress resistance and cardiac function in Drosophila.Age-dependent Increase in JNK2 Activity: Does This Help to Understand CaMKII-mediated Atrial Arrhythmogenesis in Human Atrial Fibrillation?α-Galactosidase A Genotype N215S Induces a Specific Cardiac Variant of Fabry Disease.Blocking of α4 integrin does not protect from acute ischemic stroke in mice.Efficacy and Safety of Platelet Glycoprotein Receptor Blockade in Aged and Comorbid Mice With Acute Experimental Stroke.Erratum: Cardiac RKIP induces a beneficial β-adrenoceptor-dependent positive inotropy.Myocardial Fibrosis Predicts 10-Year Survival in Patients Undergoing Aortic Valve ReplacementThe A2B adenosine receptor in MDA-MB-231 breast cancer cells diminishes ERK1/2 phosphorylation by activation of MAPK-phosphatase-1Association between Comorbidities and Progression of Transvalvular Pressure Gradients in Patients with Moderate and Severe Aortic Valve StenosisCoagulation factor XII induces pro-inflammatory cytokine responses in macrophages and promotes atherosclerosis in mice
P50
Q28580358-B99FCA7A-4D11-4CFD-8B96-3C9167F7F5F3Q28609123-EF12E237-2B9B-41F2-8051-941D69581332Q34643625-44851669-F8F2-43C9-8442-367BA1D27C03Q36318806-E5096598-5901-4DC1-A0F2-1A06152DD250Q37515818-15851BB5-4BDA-4996-BAA9-7C811C47E6C8Q37576725-6018D6CE-8EF5-495F-BC72-3087C1DF41EDQ37707024-D7D1DD98-752A-4E5C-9C46-0C9FD3A4C3F6Q38186583-224B8CDE-1319-4543-AF2A-F9ED673DF1C1Q38764430-9BC3BD41-0AE7-4F11-A5A5-AC896B323084Q38783889-9DF7AD30-7503-4F35-BDCE-82482A3F7E1CQ38932059-BC3D02FC-ACD9-4308-962B-4199BA4F2B60Q38963530-70F5ED4D-B4C7-495A-933F-9DE5BF0B497BQ39263982-B804FD7C-BE4F-4BA1-BD2E-20439401D3B2Q39801469-33140438-C836-4738-BB53-E3439290F3DFQ40025475-8C839542-A504-41A1-93AC-12A5A0F2FFB3Q40474390-60215E20-4001-4272-AC67-038E7B30240AQ40497544-A66C0E4A-A3E8-4A8D-84D5-130647EE3439Q40682968-C7CD4C6F-0C65-47C5-BCCF-F176A6AA670FQ41439084-4DE0C56D-D1EF-43B7-9DA6-F1D468D664D7Q41701185-7D3A42F3-3D10-4581-AD97-A5EF36226AB6Q41808403-E3DCCCF9-3EB4-4381-800C-10AB4754B697Q42390071-4D12F786-E5CD-40FB-9688-708D7AA11116Q44504038-19237AED-3819-4ECC-AD1C-F6CBBFDF2F24Q46211450-95C5FB93-6388-4299-917B-255BE45AC913Q47218015-C2A25358-FDE6-4BE6-A5C8-4521D6EFBEC2Q47326426-AC2546EC-3C63-4706-B1F7-0E9945C51669Q47800039-F228CE99-6E71-4BBC-91DB-CD82EA9F0859Q48118068-AF880908-48B8-4F1F-A189-8F11C94407D9Q48745381-7C3C51DF-9ADE-406D-A80E-55540BC3FECBQ49040217-9787C8DE-A311-4C7C-BCB4-AB5DD972E4B2Q49394392-EA393405-195C-4859-AE1B-3306531A7C49Q50061571-F92B9ABA-AC54-4F69-9B20-0313B4F8758BQ50091253-FC2E51CA-6435-4E38-AF18-6699FA83ABD3Q51740914-190B517F-15E7-43F6-B810-9F475B0CD5CDQ52147721-755B4617-29EA-42A2-AF5F-DBF9082EC676Q52856897-E9EB52BB-7E8C-4E90-B839-2B49F5075AC8Q57824418-52EB066A-8A2A-40AE-A63F-EEF8FB9A274CQ58696098-41BD0C58-B16F-42F4-B255-0F2D37B5622DQ59811179-8692C418-8A89-45AE-8B01-6341D70825CAQ60992266-E13F0C74-B347-4FA9-8926-FBD543D3314E
P50
description
academisch docent
@nl
hulumtuese
@sq
researcher
@en
ricercatrice
@it
taighdeoir
@ga
հետազոտող
@hy
name
Kristina Lorenz
@ast
Kristina Lorenz
@en
Kristina Lorenz
@es
Kristina Lorenz
@nl
Kristina Lorenz
@sl
type
label
Kristina Lorenz
@ast
Kristina Lorenz
@en
Kristina Lorenz
@es
Kristina Lorenz
@nl
Kristina Lorenz
@sl
prefLabel
Kristina Lorenz
@ast
Kristina Lorenz
@en
Kristina Lorenz
@es
Kristina Lorenz
@nl
Kristina Lorenz
@sl
P214
P227
P1053
F-3522-2016
P19
P21
P213
0000 0000 1682 6449
P214
P227
P31
P3829
P496
0000-0002-5747-2207
P569
1972-01-01T00:00:00Z
P734
P735
P7859
viaf-52794815